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Background: The significance of electrocardiographically determined left ventricular hypertrophy (LVH) in STEMI pts in the percutaneous coronary 
intervention era is unclear.
methods: In the HORIZONS-AMI trial, 3,602 STEMI pts were randomized to receive unfractionated heparin plus a glycoprotein IIb/IIIa inhibitor 
or bivalirudin. Endpoints included MACE (death, reinfarction, target vessel revascularization or stroke) and its components. We analyzed outcomes 
according to the presence or absence of electrographically determined LVH.
results: 3,305 pts had baseline electrocardiograms that were analyzed at a core laboratory; LVH was present in 111 patients. LVH pts had higher 
rates of co-morbid conditions. Primary PCI was more likely to be performed after angiography in pts without LVH (93.4% vs. 78.4%, p<0.0001). Pts 
with LVH had higher rates of 30-day cardiac mortality (5.4% vs. 2.2%, p=0.02) and stroke (2.8% vs. 0.6%, p=0.008). At 1 year, LVH pts had higher 
rates of all-cause mortality and stroke. Furthermore, LVH was an independent predictor of 1-year mortality or stroke (HR [CI] = 1.99 [1.04, 3.80]; 
p=0.04).
conclusion: LVH by electrocardiography identifies a STEMI pt subset with increased mortality and stroke rates. 
1-year Events LVH (n=111) No LVH (n=3194) P value
MACE 15.3% 11.9% 0.24
All-cause Death 9.5% 3.9% 0.004
Cardiac Death 5.4% 2.8% 0.09
Reinfarction 3.0% 4.0% 0.63
Stroke 3.9% 0.9% 0.006
